Tuberculosis skin test, but not interferon-γ-releasing assays is affected by BCG vaccination in HIV patients

Journal of Infection

Volumn 66, Issue 4, 2013, Pages 376-380

  Wolf, T ^a   Goetsch, U ^b   Oremek, G ^a   Bickel, M ^a   Khaykin, P ^a   Haberl, A ^a   Bellinger, O ^b   Gottschalk, R ^b   Brodt, H R ^a   Stephan, C ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Public Health Office   (Germany)

Author keywords

BCG vaccination; Human immunodeficiency virus (HIV); Interferon gamma releasing assay; Latent tuberculosis infection; Tuberculin skin test

Indexed keywords

ANTIRETROVIRUS AGENT; BCG VACCINE; GAMMA INTERFERON;

ADULT; ARTICLE; BCG VACCINATION; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GERMANY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTERFERON GAMMA RELEASING ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; TUBERCULIN TEST; UNIVERSITY HOSPITAL;

ADULT; AGED; BCG VACCINE; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; INTERVIEWS AS TOPIC; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; TUBERCULIN TEST; VACCINATION; YOUNG ADULT;

EID: 84875496894     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.11.004     Document Type: Article

References (11)

1. Horsburgh C.R. Priorities for the treatment of Latent Tuberculosis Infection in the United States. N Engl J Med 2004, 350:2060-2067.
2. MMWR, June 25th, 2010, 59(RR05); p. 1-25.
3. EACS guidelines version 6 October 2011, http://www.europeanaidsclinicalsociety.org.
4. Stephan C., Wolf T., Goetsch U., Bellinger O., Nisius G., Oremek G., et al. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV infected patients from a low prevalence country. AIDS 2008, 22(18):2471-2479.
5. Tissot F., Zanetti G., Francioli P., Zellweger J.P., Zysset F. Influence of bacilli Calmette-Guérin vaccination on size of skin test reaction: to what size?. Clin Infect Dis 2005, 40:211-217.
6. Wang L., Turner M.O., Elwood R.K., Schulzer M., FitzGerald J.M. A meta-analysis of the effect of bacill Calmette Guérin vaccination on the size of tuberculin skin test measurement. Thorax 2002, 57:804-809.
7. Pai M., Zwerling A., Menzies D. T-cell based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008, 149(3):177-184.
8. American Thoracic Society Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000, 161:S221-S247.
9. Zhang M., Wang H., Liao M., Chen X., Graner M., Zhu X., et al. Diagnosis of latent tuberculosis infection in bacille Calmette-Guerin vaccinated subjects in China bay interferon gamma ELISpot assay. Int J Tuberc Lung Dis 2010, 14(12):1556-1563.
10. Mahan C.S., Johnson D.F., Curley C., van der Kuyp F. Concordance of a positive TST and an interferon-gamma release assay in bacille Calmette-Guérin vaccinated persons. Int J Tuberc Lung Dis 2001, 15(2):174-178.
11. Lobue P.A., Castro K.G. Is it time to replace the tuberculin skin test with a blood test?. J Am Med Assoc 2012, 308(3):241-242.